Can Buying Exelixis Stock Still Make You Rich?
What were you doing on Friday, Jan. 2, 2015? It's OK if you don't remember. I certainly can't.
But there were some investors who did something on that date who probably recall it with a smile. Anyone who bought shares of Exelixis (NASDAQ: EXEL) at the beginning of 2015 and held on to the stock are now sitting on a return of 1,560%. A $10,000 investment in the biotech less than three years ago would now be worth $166,000.
Exelixis has been one of the hottest biotech stocks in recent years. But can buying this stock still make you rich? It just might.
Source: Fool.com
Pfizer Inc. Stock
€26.17
-0.270%
The stock is one of the favorites of our community with 31 Buy predictions and 4 Sell predictions.
As a result the target price of 41 € shows a very positive potential of 56.7% compared to the current price of 26.17 € for Pfizer Inc..
